| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
62,894,000 |
| Market
Cap: |
2.08(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.61 - $51.88 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. Co.'s clinical development programs include: CDX-0159, which is a human monoclonal antibody that specifically binds the receptor tyrosine kinase KIT; CDX-1140, which is a human monoclonal antibody targeted to CD40, a key activator of immune response, which is being studied in a Phase1 study; and CDX-527, which is a bispecific antibody that uses Co.'s proprietary anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which Co. has initiated a Phase 1 study in advanced solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
133,169 |
133,169 |
133,169 |
357,024 |
| Total Sell Value |
$4,512,649 |
$4,512,649 |
$4,512,649 |
$12,871,590 |
| Total People Sold |
4 |
4 |
4 |
8 |
| Total Sell Transactions |
4 |
4 |
4 |
12 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcmahon Gerald Phd |
Director |
– • – |
2018-03-01 |
4 |
D |
$2.25 |
$7,684 |
D/D |
(3,415) |
206,741 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2018-02-01 |
4 |
D |
$2.76 |
$9,425 |
D/D |
(3,415) |
210,156 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2018-01-02 |
4 |
D |
$2.84 |
$10,409 |
D/D |
(3,665) |
213,571 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-12-01 |
4 |
D |
$3.00 |
$9,636 |
D/D |
(3,212) |
217,236 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-11-01 |
4 |
D |
$2.44 |
$7,837 |
D/D |
(3,212) |
220,448 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-10-02 |
4 |
D |
$2.86 |
$9,186 |
D/D |
(3,212) |
223,660 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-09-01 |
4 |
D |
$2.46 |
$7,902 |
D/D |
(3,212) |
226,872 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-08-01 |
4 |
D |
$2.29 |
$6,570 |
D/D |
(2,869) |
230,084 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-07-03 |
4 |
D |
$2.47 |
$7,086 |
D/D |
(2,869) |
232,953 |
|
- |
|
| Cavanaugh Sarah |
SVP of Corp. Affairs & Admin.O |
• – – |
2017-06-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,760 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
235,822 |
|
- |
|
| Marino James J |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
25,997 |
|
- |
|
| Brownlie Keith L |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Lipton Karen Shoos |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
41,833 |
|
- |
|
| Conrad Herbert J |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
38,500 |
|
- |
|
| Penner Harry Jr |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
41,916 |
|
- |
|
| Ellberger Larry |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
73,500 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-06-01 |
4 |
D |
$2.83 |
$8,119 |
D/D |
(2,869) |
225,822 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-05-01 |
4 |
D |
$3.33 |
$9,554 |
D/D |
(2,869) |
228,691 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-04-03 |
4 |
D |
$3.61 |
$10,357 |
D/D |
(2,869) |
231,560 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2017-03-01 |
4 |
D |
$3.54 |
$116,562 |
D/D |
(32,927) |
234,429 |
|
- |
|
| Marino James J |
Director |
– • – |
2017-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,997 |
|
- |
|
| Mcmahon Gerald Phd |
Director |
– • – |
2016-12-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
267,356 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2016-09-02 |
4 |
OE |
$2.80 |
$28,000 |
D/D |
10,000 |
83,586 |
|
- |
|
| Keler Tibor |
Executive VP & CSO |
• – – |
2016-09-02 |
4 |
B |
$3.32 |
$9,960 |
D/D |
3,000 |
18,868 |
2.74 |
- |
|
254 Records found
|
|
Page 4 of 11 |
|
|
0.25 (0.76%) 
